Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
IS4S and GPS Source win Army OTAs to build modular, next-generation positioning, navigation and timing systems for future ground platforms.
Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...
The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...
Auto-generated creative isn’t a question of right or wrong, but of risk tolerance, brand constraints, and readiness to test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results